18
SURGICAL SITE INFECTIONS ME Macrae B.Cur 1et A III University of Pretoria Student No: 29606218 15 November 2011 Sandton MediClinic Operating Theatre ME MACRAE B.CUR 1ET A III

Surgical site infections

Embed Size (px)

DESCRIPTION

slide/share SSIsSurgical Site Infections.pptx

Citation preview

Page 1: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

SURGICAL SITE INFECTIONSME Macrae B.Cur 1et A III

University of Pretoria

Student No: 29606218

15 November 2011

Sandton MediClinic

Operating Theatre

Page 2: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

INTRODUCTION

Definition of Surgical Site Infections The incidence of SSI’s SSI nosocomial infection Economic costs of SSIs

Morbidity Mortality Re-admission Rate Length of stay Cost for patients

Evidence-based care components

Page 3: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

IMPACT

Despite the best efforts of healthcare facilities to maintain safe surgical environments, surgical site infections result in up to $10 billion in treatment costs every year in the U.S. alone

780,000 out of 30 million surgical procedures performed annually in the U.S. result in SSI.1

In the United Kingdom, the estimated direct costs for a patient who has developed a surgical site infection are between €2,265 and €2,518.2

According to a study in the Netherlands, SSIs result in 5.8 to 17 extra days of hospitalization.3

In France, approximately 11% of surgical patients acquire a surgical site infection.

Page 4: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

CARE BUNDLES

A review of the medical literature shows that the following care components reduce the incidence of SSI: Day of Surgery Admission Appropriate use of Antibiotics Appropriate hair removal Maintenance of post-operative glucose control (Major cardiac

surgical patients) Post-operative normothermia (All open abdominal surgery)

The components, if implemented reliably, drastically reduce the incidence of SSI and virtually eliminate instances of preventable SSI

Page 5: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

PREOPERATIVE PHASE

Page 6: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

DAY OF SURGERY ADMISSION (DOSA) DOSA – Obvious means of reducing preoperative hospital

stay Guidelines for Prevention of SSI recommends this Category II – Supported by suggestive clinical or

epidemiological studies Encouraged to practice DOSA where possible Document reasons for not practicing DOSA

Page 7: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

PREOPERATIVE ANTIBIOTIC PROPHYLAXIS Purpose is to reduce the impact of intraoperative microbial

contamination of a surgical site to a level that will not result in infection

Antibiotics Selection Consistent with national guidelines Special cases: Allergy, prolonged use

Timely Administration Within one hour prior to surgery (Vancomycin or Fluoroquinolones: 2 Hours) Make sure all antibiotic is infused prior to inflation of cuff

Dosage At least a full therapeutic dose Upper ranges for large patients and/or long operations Repeat doses for long operations (>4 Hours)

Page 8: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

RUN CHARTS

Jan-11 Feb-11 Mar-11 Apr-11 May-110%

20%

40%

60%

80%

100%

Hospital

Goal

ON-TIME PROHYLACTIC ANTIBIOTIC ADMINISTRATION

Series 3Series 2

% O

F P

ATIE

NTS

Page 9: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

PREOPERATIVE ANTIBIOTIC PROPHYLAXIS Timely Discontinuation

Confirmed efficacy of > 12 hours Efficacy of a single dose Shorter course has been as effective as the longer course No need to continue coverage beyond 24 Hours even with tubes and

drains postoperatively Lack of evidence preventing SSI’s if given after the end of the

operation Increased use promotes antibiotic resistance

Antibiotic Use : selection, dosage, timing, duration

Page 10: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

APPROPRIATE HAIR REMOVAL

Influence of shaving on SSI Ensure adequate supply of clippers and train staff in proper use Use Reminders Educate patients not to self-shave preoperatively Remove all razors from the entire hospital

Appropriate Inappropriate

No hair removal Razors

Clipping

Depilatory use X

Page 11: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

INTRAOPERATIVE PHASE

Page 12: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

INTRAOPERATIVE PHASE

Hand Decontamination Incise Drapes

Do not use non-iodophor-impregnated drapes routinely

Use of sterile gown and gloves Antiseptic Skin Preparation

Prepare the skin at the surgical site immediately before incision Use an antiseptic (Aqueous or alcohol based) Preparation: povidone-iodine or chlorohexidine most suitable

Diathermy Do not use diathermy for surgical incision to reduce the risk

Wound dressings Cover surgical incisions with an appropriate interactive dressing

Page 13: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

PERIOPERATIVE NORMOTHERMIA

Hypothermia reduces tissue oxygen tension by vasoconstriction

Hypothermia reduces leukocyte superoxide production Hypothermia increases bleeding and transfusion

requirement Hypothermia increases duration of hospital stay even in

uninfected patients

X

Page 14: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

POSTOPERATIVE PHASE

Page 15: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

DRESSING FOR WOUND HEALING Changing Dressings

Use an aseptic non-touch technique for changing or removing surgical wound dressing

Post-Operative Cleansing Sterile saline for wound cleansing up to 48 Hours after surgery Advise patients they can shower safely after 48 Hours

Wounds healing by primary intention Do not use topical antimicrobial agents to reduce risk of SSI

Dressings for wound healing by secondary intention Refer to tissue viability nurse for advice on appropriate dressings for the

management of surgical wounds that are healing by secondary intention Do not use Eusol and gauze

Page 16: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

POST OPERATIVE SERUM GLUCOSE DETERMINATION Hyperglycemia or and risk of SSI No increased risk

Elevated HgbA1C Preoperative hyperglycemia

Increased Risk Diagnosed Diabetes Undiagnosed Diabetes Post-operative glucose > 200mg% within 48 Hours

Page 17: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

CONCLUSION

ljhkj

Page 18: Surgical site infections

ME MACRAE B.CUR 1ET A I I I

REFERENCES

Cook, R. “Hospitals learn simple, cheap steps can prevent infections,” San Francisco Chronicle, May 18,

2004; F1.

Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, et al. The cost of infection in surgical

patients: a case–control study. J Hosp Infect 1993; 24(4):239–50., and Plowman R, Graves N, Griffin MA,

Roberts JA, Swan AV, Cookson, B, et al. The rate and cost of hospital–acquired infections occurring in

patients admitted to selected specialties of a district general hospital in England and the national burden

imposed. J Hosp Infect 2001; 47(3):198–209.

Geubbels EL, Mintjes–de Groot AJ, Van den Berg JM, de Boer AS. An operating surveillance system of

surgical site infections in the Netherlands: results of the PREZIES national surveillance network.

Prevenzxztie van Ziekenhuis infecties door Surveillance. Infect Control Hosp Epidemiol 2000; 21 (5): 107.

Source: Prevalence of nosocomial infections in France; results of the nationwide survey in 1996. Journal of

Hospital Infection. 2000; 46:186–193

http://www.ncbi.nlm.nih.gov/pubmed/9527963

Safer Systems – Saving Lives Preventing Surgical Site Infection – Version 4

http://www.health.vic.gov.au/sssl/downloads/prev_surgical.pdf Copyright State of Victoria, Department of

Human Services, 2005.